The time has not yet come to remove your chips from the table: Sunshine Biopharma Inc (SBFM)

With 67.72 million shares changed hands, the volume of the stock remained heavier than its average volume of 87230.0 shares. The 52-week range on SBFM shows that it touched its highest point at $248.00 and its lowest point at $1.90 during that stretch. It currently has a 1-year price target of $15.00. Beta for the stock currently stands at 1.18.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SBFM was up-trending over the past week, with a rise of 5.63%, but this was up by 5.19% over a month. Three-month performance dropped to -19.93% while six-month performance fell -29.25%. The stock lost -98.94% in the past year, while it has lost -25.00% so far this year. A look at the trailing 12-month EPS for SBFM yields -51.76 with Next year EPS estimates of 0.74. For the next quarter, that number is 0.01. This implies an EPS growth rate of 98.92% for this year and 117.96% for next year.

Float and Shares Shorts:

At present, 2.71 million SBFM shares are outstanding with a float of 2.71 million shares on hand for trading.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. The EBITDA in the recently reported quarter was -$933105.0 and diluted EPS was -$0.94.

Analysts Ratings:

In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$4.12 being high and -$4.12 being low. For SBFM, this leads to a yearly average estimate of -$4.12.